H. Lundbeck As - About Mood Disorders

Shares in Danish pharmaceutical group H. Lundbeck plummeted Monday after it said it would be up to two years late in submitting a new anti-depressant to US authorities for approval.The company, which is developing the drug in conjunction with the Japanese firm ...